Literature DB >> 7017406

The anthracycline antineoplastic drugs.

R C Young, R F Ozols, C E Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7017406     DOI： 10.1056/NEJM198107163050305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  153 in total

Review 1.  Cardiotoxicity of doxorubicin and other anthracycline derivatives.

Authors:  D Jain
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 2.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

Review 3.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

4.  Cytotoxic properties of iron-hydroxynaphthoquinone complexes in rat hepatocytes.

Authors:  A Kumbhar; S Padhye; D Ross
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

Review 5.  Drug treatment of acute leukaemia. Current status.

Authors:  S M Donohue; C P Charlton
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

6.  Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Nanomater       Date:  2012       Impact factor: 2.986

7.  Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.

Authors:  W P McGuire; J A Blessing; M L Berman
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

Review 8.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

9.  Thermal stability of DNA adducts induced by cyanomorpholinoadriamycin in vitro.

Authors:  C Cullinane; D R Phillips
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

10.  Genetic variants contributing to daunorubicin-induced cytotoxicity.

Authors:  R Stephanie Huang; Shiwei Duan; Emily O Kistner; Wasim K Bleibel; Shannon M Delaney; Donna L Fackenthal; Soma Das; M Eileen Dolan
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.